News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,831 Results
Type
Article (146)
Press Release (1685)
Section
Business (514)
Career Advice (1)
Deals (120)
Drug Development (344)
FDA (39)
Job Trends (32)
News (946)
Policy (89)
Tag
Academia (4)
Accelerated approval (1)
Adcomms (2)
Alliances (80)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (1)
Approvals (36)
Artificial intelligence (1)
Autoimmune disease (1)
Best Places to Work (33)
Brain cancer (2)
Breast cancer (6)
Cancer (21)
Career advice (1)
CAR-T (5)
Cell therapy (8)
Clinical research (331)
Collaboration (7)
Compensation (18)
COVID-19 (16)
C-suite (3)
Data (53)
Depression (2)
Diabetes (2)
Diagnostics (8)
Drug discovery (1)
Earnings (368)
Events (404)
Executive appointments (3)
FDA (63)
Funding (3)
Generative AI (1)
Gene therapy (2)
GLP-1 (7)
Government (12)
Guidances (2)
Healthcare (27)
Immunology and inflammation (7)
Indications (1)
Infectious disease (18)
Influenza (1)
Intellectual property (1)
IPO (81)
Job creations (2)
Job search strategy (1)
Layoffs (4)
Legal (7)
Liver cancer (2)
Lymphoma (1)
Manufacturing (4)
MASH (2)
Medical device (14)
Medtech (15)
Mergers & acquisitions (44)
Metabolic disorders (6)
Neuroscience (5)
NextGen: Class of 2026 (22)
Non-profit (1)
Obesity (1)
Patents (1)
Patient recruitment (3)
People (98)
Phase 1 (91)
Phase 2 (164)
Phase 3 (128)
Pipeline (60)
Postmarket research (5)
Preclinical (28)
Psychedelics (2)
Radiopharmaceuticals (5)
Rare diseases (24)
Real estate (5)
Regulatory (108)
Research institute (3)
RSV (1)
Startups (4)
Vaccines (1)
Venture capital (1)
Date
Today (1)
Last 7 days (7)
Last 30 days (24)
Last 365 days (151)
2026 (72)
2025 (155)
2024 (233)
2023 (202)
2022 (238)
2021 (247)
2020 (147)
2019 (159)
2018 (91)
2017 (116)
2016 (54)
2015 (48)
2014 (25)
2013 (14)
2012 (6)
2011 (9)
2010 (4)
Location
Africa (1)
Arizona (5)
Asia (117)
Australia (1)
California (121)
Canada (5)
Europe (292)
Florida (2)
Illinois (6)
India (3)
Japan (1)
Maryland (52)
Massachusetts (45)
Minnesota (3)
New Jersey (28)
New York (9)
North Carolina (37)
Northern California (83)
Ohio (1)
Pennsylvania (3)
South America (2)
Southern California (24)
Texas (33)
United States (305)
Utah (1)
1,831 Results for "perlara pbc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC
May 28, 2026
·
10 min read
Press Releases
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026
May 14, 2026
·
13 min read
Press Releases
Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
May 28, 2026
·
7 min read
Press Releases
Gilead’s Livdelzi® (Seladelpar) Delivers Statistically Significant Composite ALP Normalization in Phase 3 IDEAL Trial in Primary Biliary Cholangitis (PBC)
June 2, 2026
·
11 min read
Press Releases
PBC Biomed Appoints Mark McMahan as Chief Commercial Officer
October 7, 2025
·
1 min read
Press Releases
Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID
October 30, 2025
·
4 min read
Press Releases
Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue
November 10, 2025
·
11 min read
Press Releases
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression
November 10, 2025
·
14 min read
Press Releases
Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary Biliary Cholangitis (PBC) and Investigational Bulevirtide in Chronic Hepatitis Delta
October 24, 2025
·
17 min read
Press Releases
Intercept Announces Voluntary Withdrawal of OCALIVA® for Primary Biliary Cholangitis (PBC) from the US Market; US Clinical Trials Involving Obeticholic Acid Placed on Clinical Hold
September 12, 2025
·
9 min read
1 of 184
Next
